Track topics on Twitter Track topics that are important to you
245 Fifth Avenue4th Floor
United States of America
Phone: 1 212 686 7400
Fax: 1 212 686 2626
With Takeda’s £46 billion acquisition of Shire, it’s been a busy year for pharma M&A – and according to analysts Datamonitor, the specialist biotechs Nektar, BioMarin and Alnylam are the pi...
Although norovirus infections are implicated in roughly 200,000 deaths per year, there are only four candidates in clinical development, Datamonitor...
As generic competition to J&J's Zytiga starts to line up ahead of possible launches in October, Datamonitor Healthcare has been...
The top two high-priority challenges to address in asthma treatment for respondents to a large survey by Datamonitor Healthcare of...
Gilead has once more been mentioned as a prospective acquirer of Tesaro, but analysts at Datamonitor Healthcare's PharmaVitae believe that...
Subscribe to MarketLine’s Business Information Center (MBIC) and instantly access a comprehensive source of information on 10,000 companies, 2,000 industries and 50 countries – featuring profiles,...
We have published hundreds of Datamonitor news stories on BioPortfolio along with dozens of Datamonitor Clinical Trials and PubMed Articles about Datamonitor for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Datamonitor Companies in our database. You can also find out about relevant Datamonitor Drugs and Medications on this site too.